Joseph Sakai
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conduct Disorder | 29 | 2025 | 160 | 8.910 |
Why?
| | Substance-Related Disorders | 31 | 2025 | 1054 | 4.050 |
Why?
| | Adolescent Behavior | 10 | 2025 | 500 | 3.400 |
Why?
| | Emotions | 13 | 2025 | 577 | 3.200 |
Why?
| | Empathy | 10 | 2025 | 181 | 3.110 |
Why?
| | Antisocial Personality Disorder | 14 | 2025 | 121 | 2.750 |
Why?
| | Theory of Mind | 3 | 2025 | 15 | 2.560 |
Why?
| | Psychiatry | 5 | 2026 | 186 | 1.670 |
Why?
| | Executive Function | 3 | 2025 | 457 | 1.450 |
Why?
| | Cognition | 6 | 2025 | 1258 | 1.400 |
Why?
| | Cannabis | 5 | 2025 | 509 | 1.350 |
Why?
| | Morals | 2 | 2023 | 80 | 1.250 |
Why?
| | Students, Medical | 4 | 2023 | 373 | 1.170 |
Why?
| | Mental Disorders | 9 | 2025 | 1138 | 1.150 |
Why?
| | Adolescent | 50 | 2025 | 22281 | 1.110 |
Why?
| | Risk-Taking | 8 | 2023 | 323 | 1.110 |
Why?
| | Social Behavior | 2 | 2025 | 288 | 1.070 |
Why?
| | Helping Behavior | 2 | 2019 | 20 | 1.050 |
Why?
| | Brain | 11 | 2025 | 2930 | 0.940 |
Why?
| | Connectome | 2 | 2023 | 95 | 0.900 |
Why?
| | Altruism | 2 | 2023 | 28 | 0.890 |
Why?
| | Affect | 2 | 2025 | 318 | 0.890 |
Why?
| | Medical Marijuana | 3 | 2017 | 123 | 0.850 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2010 | 62 | 0.820 |
Why?
| | Career Mobility | 1 | 2024 | 70 | 0.820 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 139 | 0.810 |
Why?
| | Clinical Clerkship | 2 | 2023 | 110 | 0.810 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 576 | 0.800 |
Why?
| | Awards and Prizes | 1 | 2024 | 70 | 0.800 |
Why?
| | Alcoholism | 11 | 2014 | 808 | 0.770 |
Why?
| | Psychology, Adolescent | 2 | 2016 | 63 | 0.770 |
Why?
| | Binge Drinking | 1 | 2023 | 44 | 0.740 |
Why?
| | Cerebral Cortex | 5 | 2017 | 464 | 0.700 |
Why?
| | Models, Psychological | 1 | 2023 | 296 | 0.690 |
Why?
| | Motivation | 2 | 2025 | 605 | 0.680 |
Why?
| | Faculty, Medical | 1 | 2024 | 301 | 0.670 |
Why?
| | Marijuana Abuse | 5 | 2017 | 211 | 0.670 |
Why?
| | Decision Making | 7 | 2017 | 974 | 0.660 |
Why?
| | Tobacco Products | 1 | 2022 | 84 | 0.660 |
Why?
| | Vaping | 1 | 2022 | 66 | 0.650 |
Why?
| | Humans | 82 | 2026 | 144261 | 0.630 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 108 | 0.630 |
Why?
| | Male | 59 | 2026 | 72035 | 0.600 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 249 | 0.600 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 50 | 0.590 |
Why?
| | Magnetic Resonance Imaging | 16 | 2025 | 3857 | 0.580 |
Why?
| | Female | 55 | 2026 | 77976 | 0.560 |
Why?
| | Education, Medical | 1 | 2021 | 273 | 0.550 |
Why?
| | Gray Matter | 2 | 2015 | 88 | 0.530 |
Why?
| | Nerve Net | 2 | 2025 | 285 | 0.490 |
Why?
| | Case-Control Studies | 11 | 2023 | 3592 | 0.480 |
Why?
| | Gift Giving | 1 | 2016 | 9 | 0.480 |
Why?
| | Affective Symptoms | 1 | 2016 | 53 | 0.460 |
Why?
| | Physicians | 1 | 2024 | 938 | 0.460 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2014 | 2143 | 0.450 |
Why?
| | Depression | 2 | 2024 | 1533 | 0.430 |
Why?
| | Reward | 4 | 2025 | 245 | 0.430 |
Why?
| | Suicide | 1 | 2021 | 691 | 0.410 |
Why?
| | Problem Behavior | 1 | 2015 | 101 | 0.410 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 138 | 0.370 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 20 | 0.360 |
Why?
| | Alcohol Drinking | 4 | 2023 | 812 | 0.350 |
Why?
| | Marijuana Smoking | 2 | 2014 | 250 | 0.350 |
Why?
| | Psychomotor Performance | 1 | 2013 | 328 | 0.330 |
Why?
| | United States | 13 | 2024 | 15876 | 0.320 |
Why?
| | Sex Characteristics | 3 | 2023 | 789 | 0.320 |
Why?
| | Ethanol | 2 | 2023 | 625 | 0.300 |
Why?
| | Receptors, Dopamine D2 | 2 | 2007 | 93 | 0.290 |
Why?
| | Marijuana Use | 2 | 2025 | 213 | 0.290 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2009 | 223 | 0.280 |
Why?
| | Mental Health | 3 | 2025 | 776 | 0.270 |
Why?
| | Legislation, Drug | 2 | 2022 | 73 | 0.270 |
Why?
| | Games, Experimental | 2 | 2019 | 13 | 0.270 |
Why?
| | Tegafur | 1 | 2026 | 12 | 0.240 |
Why?
| | Oxonic Acid | 1 | 2026 | 13 | 0.240 |
Why?
| | Polymorphism, Genetic | 3 | 2006 | 612 | 0.240 |
Why?
| | Neuroimaging | 3 | 2019 | 289 | 0.240 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2026 | 11 | 0.240 |
Why?
| | Adult | 26 | 2026 | 40262 | 0.240 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 118 | 0.240 |
Why?
| | Literacy | 1 | 2026 | 13 | 0.240 |
Why?
| | Aggression | 2 | 2009 | 179 | 0.240 |
Why?
| | Amphetamine-Related Disorders | 2 | 2025 | 47 | 0.230 |
Why?
| | Corneal Diseases | 1 | 2026 | 46 | 0.230 |
Why?
| | Child | 14 | 2025 | 22537 | 0.230 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2026 | 105 | 0.230 |
Why?
| | Reproducibility of Results | 5 | 2023 | 3403 | 0.230 |
Why?
| | Curriculum | 2 | 2026 | 1057 | 0.230 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 108 | 0.230 |
Why?
| | Young Adult | 9 | 2024 | 13990 | 0.220 |
Why?
| | Monitoring, Ambulatory | 1 | 2006 | 88 | 0.220 |
Why?
| | Colorado | 9 | 2020 | 4562 | 0.220 |
Why?
| | Brain Mapping | 5 | 2019 | 536 | 0.220 |
Why?
| | Substance Abuse Detection | 1 | 2006 | 105 | 0.210 |
Why?
| | Methamphetamine | 1 | 2025 | 68 | 0.210 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 780 | 0.210 |
Why?
| | Guilt | 1 | 2023 | 11 | 0.200 |
Why?
| | Charities | 1 | 2023 | 13 | 0.200 |
Why?
| | Reaction Time | 1 | 2025 | 438 | 0.190 |
Why?
| | Marriage | 1 | 2004 | 122 | 0.190 |
Why?
| | Central Nervous System Stimulants | 1 | 2025 | 182 | 0.190 |
Why?
| | Siblings | 3 | 2009 | 195 | 0.190 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 328 | 0.190 |
Why?
| | Happiness | 1 | 2022 | 23 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 230 | 0.180 |
Why?
| | Odds Ratio | 2 | 2020 | 1072 | 0.180 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1255 | 0.180 |
Why?
| | Impulsive Behavior | 2 | 2015 | 144 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 355 | 0.180 |
Why?
| | Cannabidiol | 1 | 2024 | 136 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 149 | 0.180 |
Why?
| | Unsafe Sex | 2 | 2020 | 60 | 0.180 |
Why?
| | Deep Brain Stimulation | 1 | 2025 | 212 | 0.170 |
Why?
| | Electronics | 1 | 2022 | 70 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 2 | 2008 | 2359 | 0.170 |
Why?
| | Linkage Disequilibrium | 4 | 2008 | 246 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 301 | 0.170 |
Why?
| | Prevalence | 7 | 2024 | 2815 | 0.170 |
Why?
| | Education, Medical, Graduate | 1 | 2026 | 557 | 0.160 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5813 | 0.160 |
Why?
| | Family | 4 | 2009 | 679 | 0.160 |
Why?
| | Enuresis | 1 | 2000 | 3 | 0.160 |
Why?
| | Double-Blind Method | 1 | 2025 | 2025 | 0.160 |
Why?
| | Phenotype | 4 | 2010 | 3157 | 0.160 |
Why?
| | Educational Measurement | 1 | 2023 | 325 | 0.150 |
Why?
| | Genotype | 5 | 2014 | 1833 | 0.150 |
Why?
| | Tandem Repeat Sequences | 1 | 1999 | 22 | 0.150 |
Why?
| | Receptors, Dopamine | 1 | 1999 | 19 | 0.150 |
Why?
| | Biomedical Research | 1 | 2026 | 709 | 0.150 |
Why?
| | Data Collection | 2 | 2014 | 633 | 0.150 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 70 | 0.150 |
Why?
| | Tobacco Use | 1 | 2020 | 61 | 0.150 |
Why?
| | Social Stigma | 1 | 2021 | 158 | 0.150 |
Why?
| | Substance Abuse, Intravenous | 2 | 2013 | 127 | 0.150 |
Why?
| | Craving | 1 | 2019 | 39 | 0.150 |
Why?
| | Fear | 1 | 2022 | 366 | 0.140 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 8 | 0.140 |
Why?
| | Logistic Models | 3 | 2020 | 2104 | 0.140 |
Why?
| | Education, Distance | 1 | 2019 | 61 | 0.140 |
Why?
| | Adolescent Development | 1 | 2019 | 72 | 0.140 |
Why?
| | Multimodal Imaging | 1 | 2019 | 124 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2005 | 878 | 0.140 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 153 | 0.140 |
Why?
| | Tuberculin Test | 1 | 1998 | 36 | 0.140 |
Why?
| | Sex Factors | 4 | 2017 | 2096 | 0.140 |
Why?
| | Sleep | 1 | 2025 | 901 | 0.130 |
Why?
| | Automobile Driving | 1 | 2020 | 155 | 0.130 |
Why?
| | Physicians, Family | 1 | 2018 | 173 | 0.130 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1998 | 131 | 0.130 |
Why?
| | Clinical Competence | 2 | 2023 | 1241 | 0.130 |
Why?
| | Comorbidity | 7 | 2015 | 1646 | 0.120 |
Why?
| | Writing | 1 | 2018 | 100 | 0.120 |
Why?
| | Organ Size | 2 | 2015 | 462 | 0.120 |
Why?
| | Surveys and Questionnaires | 6 | 2018 | 6021 | 0.120 |
Why?
| | Risk Factors | 7 | 2026 | 10699 | 0.120 |
Why?
| | Drug Prescriptions | 1 | 2018 | 280 | 0.120 |
Why?
| | Violence | 1 | 2019 | 280 | 0.120 |
Why?
| | Moral Obligations | 1 | 2016 | 15 | 0.120 |
Why?
| | California | 1 | 2017 | 469 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 527 | 0.120 |
Why?
| | Photic Stimulation | 1 | 2017 | 264 | 0.120 |
Why?
| | Suicide, Attempted | 1 | 2020 | 404 | 0.120 |
Why?
| | Mental Competency | 1 | 2015 | 26 | 0.120 |
Why?
| | Research Subjects | 1 | 2015 | 41 | 0.120 |
Why?
| | Suicidal Ideation | 1 | 2021 | 564 | 0.120 |
Why?
| | Genetics, Population | 2 | 2007 | 214 | 0.110 |
Why?
| | Psychotic Disorders | 1 | 1998 | 182 | 0.110 |
Why?
| | Parents | 1 | 2004 | 1401 | 0.110 |
Why?
| | Self Report | 2 | 2020 | 863 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2000 | 299 | 0.110 |
Why?
| | Frontal Lobe | 2 | 2015 | 159 | 0.110 |
Why?
| | Internship and Residency | 1 | 2026 | 1255 | 0.110 |
Why?
| | Gambling | 1 | 2015 | 30 | 0.110 |
Why?
| | Biological Specimen Banks | 1 | 2015 | 101 | 0.110 |
Why?
| | Learning | 1 | 2019 | 449 | 0.110 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 1999 | 425 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2018 | 704 | 0.100 |
Why?
| | Informed Consent | 1 | 2015 | 198 | 0.100 |
Why?
| | Middle Aged | 12 | 2026 | 35762 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2007 | 64 | 0.090 |
Why?
| | Juvenile Delinquency | 3 | 2008 | 95 | 0.090 |
Why?
| | Accidents, Traffic | 1 | 2014 | 190 | 0.090 |
Why?
| | Limbic System | 1 | 2012 | 55 | 0.090 |
Why?
| | Attitude | 1 | 2014 | 259 | 0.090 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2019 | 151 | 0.090 |
Why?
| | Longitudinal Studies | 5 | 2014 | 2926 | 0.090 |
Why?
| | DNA Primers | 2 | 2010 | 511 | 0.080 |
Why?
| | Alleles | 2 | 2007 | 878 | 0.080 |
Why?
| | Follow-Up Studies | 3 | 2026 | 5389 | 0.080 |
Why?
| | Genomics | 1 | 2015 | 833 | 0.080 |
Why?
| | Hawaii | 1 | 2010 | 46 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1131 | 0.080 |
Why?
| | Nuclear Family | 1 | 2009 | 52 | 0.080 |
Why?
| | Age Factors | 2 | 2014 | 3313 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 481 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 484 | 0.070 |
Why?
| | Urban Population | 1 | 2012 | 490 | 0.070 |
Why?
| | Receptors, Serotonin | 2 | 2000 | 35 | 0.070 |
Why?
| | Base Sequence | 2 | 2010 | 2187 | 0.070 |
Why?
| | Diseases in Twins | 1 | 2009 | 115 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1710 | 0.070 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 59 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 13 | 0.070 |
Why?
| | Acculturation | 1 | 2007 | 54 | 0.060 |
Why?
| | Mouth Mucosa | 1 | 2007 | 88 | 0.060 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 109 | 0.060 |
Why?
| | Taq Polymerase | 1 | 2006 | 8 | 0.060 |
Why?
| | Transcription, Genetic | 2 | 2007 | 1495 | 0.060 |
Why?
| | Inheritance Patterns | 1 | 2006 | 44 | 0.060 |
Why?
| | Twins, Monozygotic | 1 | 2007 | 134 | 0.060 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 152 | 0.060 |
Why?
| | Hospitals, Veterans | 1 | 2007 | 259 | 0.060 |
Why?
| | Water Loss, Insensible | 1 | 2006 | 4 | 0.060 |
Why?
| | Japan | 1 | 2026 | 143 | 0.060 |
Why?
| | Residential Treatment | 1 | 2006 | 26 | 0.060 |
Why?
| | Breath Tests | 1 | 2006 | 79 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 797 | 0.060 |
Why?
| | Demography | 1 | 2006 | 284 | 0.050 |
Why?
| | Regression Analysis | 1 | 2007 | 998 | 0.050 |
Why?
| | Alcoholic Intoxication | 1 | 2006 | 74 | 0.050 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 1182 | 0.050 |
Why?
| | Drug Combinations | 1 | 2026 | 390 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2006 | 218 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2006 | 574 | 0.050 |
Why?
| | Twins | 1 | 2025 | 156 | 0.050 |
Why?
| | Hospitals, University | 1 | 2004 | 176 | 0.050 |
Why?
| | Smoking | 2 | 2012 | 1468 | 0.050 |
Why?
| | Equipment Design | 1 | 2006 | 530 | 0.050 |
Why?
| | Acute Coronary Syndrome | 1 | 2007 | 293 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 778 | 0.050 |
Why?
| | Genetic Variation | 2 | 1999 | 982 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 427 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2026 | 8243 | 0.050 |
Why?
| | Canada | 1 | 2024 | 428 | 0.050 |
Why?
| | Incidence | 2 | 2026 | 2870 | 0.050 |
Why?
| | DNA | 2 | 2007 | 1460 | 0.040 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 706 | 0.040 |
Why?
| | Aged | 5 | 2026 | 25850 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2026 | 0.040 |
Why?
| | Prospective Studies | 3 | 2026 | 7970 | 0.040 |
Why?
| | Psychometrics | 3 | 2009 | 730 | 0.040 |
Why?
| | Interview, Psychological | 2 | 2012 | 93 | 0.040 |
Why?
| | Substance Abuse Treatment Centers | 2 | 2012 | 46 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2000 | 81 | 0.040 |
Why?
| | Receptors, LDL | 1 | 1998 | 53 | 0.040 |
Why?
| | Multigene Family | 1 | 1999 | 203 | 0.040 |
Why?
| | Child Abuse | 1 | 2004 | 550 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 61 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2024 | 592 | 0.030 |
Why?
| | Genetic Markers | 1 | 1999 | 331 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 154 | 0.030 |
Why?
| | HIV Infections | 1 | 2013 | 3079 | 0.030 |
Why?
| | Attention | 1 | 2021 | 455 | 0.030 |
Why?
| | Health Surveys | 2 | 2012 | 510 | 0.030 |
Why?
| | Tonsillectomy | 1 | 2000 | 105 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 323 | 0.030 |
Why?
| | Epidemics | 1 | 2018 | 98 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 72 | 0.030 |
Why?
| | Cues | 1 | 2019 | 326 | 0.030 |
Why?
| | Anxiety | 1 | 2024 | 1104 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2917 | 0.030 |
Why?
| | Game Theory | 1 | 2015 | 7 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2015 | 22 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2018 | 204 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 7155 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1983 | 0.020 |
Why?
| | Condoms | 1 | 2013 | 99 | 0.020 |
Why?
| | Radiography | 1 | 2015 | 842 | 0.020 |
Why?
| | Heroin Dependence | 1 | 2012 | 33 | 0.020 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 96 | 0.020 |
Why?
| | Family Conflict | 1 | 2012 | 43 | 0.020 |
Why?
| | Sexual Partners | 1 | 2013 | 187 | 0.020 |
Why?
| | Schizophrenia | 1 | 1996 | 444 | 0.020 |
Why?
| | Family Relations | 1 | 2012 | 88 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2012 | 130 | 0.020 |
Why?
| | Pregnancy | 1 | 2024 | 7180 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1054 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 311 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 11643 | 0.020 |
Why?
| | Social Environment | 1 | 2012 | 254 | 0.020 |
Why?
| | Patient Admission | 1 | 2012 | 218 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1347 | 0.020 |
Why?
| | Cerebellum | 1 | 2011 | 223 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2007 | 17009 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1533 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 134 | 0.020 |
Why?
| | Receptor, Serotonin, 5-HT2A | 2 | 2000 | 18 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2012 | 1129 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 965 | 0.020 |
Why?
| | Sex Distribution | 1 | 2007 | 380 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3637 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 371 | 0.010 |
Why?
| | Age of Onset | 1 | 2006 | 536 | 0.010 |
Why?
| | Health Services Research | 1 | 2007 | 394 | 0.010 |
Why?
| | Models, Genetic | 1 | 2007 | 535 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1382 | 0.010 |
Why?
| | Nicotine | 1 | 2006 | 331 | 0.010 |
Why?
| | Schools | 1 | 2006 | 452 | 0.010 |
Why?
| | Perception | 1 | 2006 | 377 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 2007 | 765 | 0.010 |
Why?
| | Molecular Sequence Data | 2 | 1998 | 2929 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2007 | 1027 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1487 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1834 | 0.010 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2000 | 8 | 0.010 |
Why?
| | Receptor, Serotonin, 5-HT2C | 1 | 2000 | 14 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1208 | 0.010 |
Why?
| | Threonine | 1 | 1998 | 46 | 0.010 |
Why?
| | Cricetinae | 1 | 1998 | 303 | 0.010 |
Why?
| | Glycosylation | 1 | 1998 | 172 | 0.010 |
Why?
| | Organ Specificity | 1 | 1998 | 312 | 0.010 |
Why?
| | Serine | 1 | 1998 | 145 | 0.010 |
Why?
| | Rabbits | 1 | 1998 | 648 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 981 | 0.010 |
Why?
| | Alternative Splicing | 1 | 1998 | 247 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 938 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 1998 | 477 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1367 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1998 | 2154 | 0.010 |
Why?
| | Myocardium | 1 | 1998 | 939 | 0.010 |
Why?
| | Cell Line | 1 | 1998 | 2879 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 1998 | 1792 | 0.000 |
Why?
| | Animals | 1 | 1998 | 38030 | 0.000 |
Why?
|
|
Sakai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|